Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2003-05-15
2008-12-09
Yaen, Christopher H (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07462458
ABSTRACT:
Methods for diagnosing ovarian neoplasia, monitoring ovarian cancer therapy, and monitoring progression of disease in subjects based on the level of the proform of major basic protein in biological samples from the subjects are described.
REFERENCES:
patent: 4034074 (1977-07-01), Miles
patent: 4098876 (1978-07-01), Piasio et al.
patent: 4233402 (1980-11-01), Maggio et al.
patent: 5296347 (1994-03-01), LaMotte, III
GenBank Accession No. P13727 dated Jan. 1, 1990, 8 pages.
Auersperg et al., “The Biology of Ovarian Cancer,”Semin. Oncol., 1998, 25(3):281-304.
Ausubel et al. (eds.), “Immunology,”Short Protocols in Molecular Biology, 1992, Chapter 11, Green Publishing Associates and John Wiley & Sons, pp. 11-1, through 11-54.
Balagopal et al., “Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise,”Am J. Physiol. Endocrinol. Metab., 2001, 280:E203-E208.
Chaurand et al., “Peptide and Protein Identification by Matrix-Assisted Laser Desorption Ionization (MALDI) and MALDI-Post-Source Decay Time-of-Flight Mass Spectrometry,”J. Am. Soc. Mass Spectrom., 1999, 10(2):91-103.
Chen and Xu, “Determination of lysophosphatidic acids by capillary electrophoresis with indirect ultraviolet detection,”J. Chromatogr. B., 2001, 753(2):355-363.
Chen et al., “Molecular Regulation of the IGF-Binding Protein-4 Protease System in Human Fibroblasts: Identification of a Novel Inducible Inhibitor,”Endocrinol., 2002, 143(4):1199-1205.
Christiansen et al., “The Proform of Eosinophil Major Basic Protein: A New Maternal Serum Marker for Down Syndrome,”Prenatal Diagnosis, 1999, 19:905-910.
Christiansen et al,, “Quantification and Characterization of Pregnancy-Associated Complexes of Angiotensinogen and the Proform of Eosinophil Major Basic Protein in Serum and Amniotic Fluid,”Clin, Chem., 2000, 46:1099-1105.
Cole et al., “The EBV-Hybridoma Technique and Its Application to Human Lung Cancer,”Monoclonal Antibodies and Cancer Therapy, 1985, Alan R. Liss, Inc., pp. 77-96.
Cote et al., “Generation of human monoclonal antibodies reactive with cellular antigens,”Proc. Natl. Acad. Sci USA, 1983, 80:2026-2030.
Conover et al., “Insulin-Like Growth Factor-Binding Protein-1 Expression in Cultured Human Bone Cells: Regulation by Insulin and Glucocorticoid,”Endocrinol., 1996, 137(8):3295-3301.
Conover et al., “Pregnancy-Associated Plasma Protein-A is the Insulin-Like Growth Factor Binding Protein-4 Protease Secreted by Human Ovarian Granulosa Cells and Is a Marker of Dominant Follicle Selection and the Corpus Luteum,”Endocrinol., 2001, 142(5):2155-2158.
Einhorn et al., “Prospective Evaluation of Serum CA 125 Levels for Early Detection of Ovarian Cancer,”Obstet. Gynecol., 1992, 80(1)14-18.
Folkman, “A New Link in Ovarian Cancer Angiogenesis: Lysophosphatidic Acid and Vascular Endothelial Growth Factor Expression,”J. Natl. Cancer Inst., 2001, 93(10):734-735.
Gevaert et al., “Protein identification based on matrix assisted laser desorption/ionization-post source decay-mass spectrometry,”Electrophoresis, 22(9):1645-1651.
Giudice et al., “Identification and Regulation of the IGFBP-4 Protease and Its Physiological Inhibitor in Human Trophoblasts and Endometrial Stroma: Evidence for Paracrine Regulation of IGF-II Bioavailability in the Placental Bed during Human Implantation,”J. Clin. Endocrinol. Metab., 2002, 87(5):2359-2366.
Guatelli et al., “Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication,”Proc. Natl. Acad. Sci. USA, 1990, 87:1874-1878.
Gurian et al., “Major basic protein as a marker of malignant potential in trophoblastic neoplasia,”Am. J. Obstet. Gynecol., 1996, 175(3):632-637.
Holschneider et al., “Ovarian Cancer: Epidermiology, Biology, and Prognostic Factors,”Semin. Surg. Oncol., 2000, 19:3-10.
Huse et al., “Gerneration of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda,”Science, 1989, 246:1275-1281.
Jat and Sharp, “Cell Lines Established by a Temperature-Sensitive Simian Virus 40 Large-T-Antigen Gene Are Growth Restricted at the Nonpermissive Temperature,”Mol. Cell. Biol., 1989, 9(4):1672-1681.
Kalli et al., “Pregnancy-associated plasma protein-A (PAPP-A) expression and insulin-like growth factor binding protein-4 protease activity in normal and malignant ovarian surface epithelial cells,”Int. J.Cancer, 2004, 110(5):633-640.
Köhler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,”Nature, 1975, 256:495-497.
Kozbor and Roder, “The production of monoclonal antibodies form human lymphocytes,”Immunology Today, 1983, 4:72-79.
Kruk et al., “A Simplified Method to Culture Human Ovarian Surface Epithelium,”Lab. Invest., 1990, 63:132-136.
Lawrence et al., “The insulin-like growth factor (IFG)-dependent IGF binding protein-4 protease secreted by human fibroblasts in pregnancy-associated plasma protein-A,”Proc. Natl. Acad. Sci.USA, 1999, 96:3149-3153.
Lewis, “PCR's Competitors Are Alive and Well and Moving Rapidly Towards Commercialization,”Genetic Engineering News, 1992, 12(9):1-3.
Mukai et al., “Elevated serum levels of eosinophil major basic protein in patients with myeloproliferative disorders without eosinophilia,”Int. J. Hematol., 1997, 66(2):197-202.
Orsulic et al., “Induction of ovarian cancer by defined multiple genetic changes in a mouse model system,”Cancer Cell, 2002, 1:53-62.
Oxvig et al., “Identification of Angiotensinogen and Complement C3dg as Novel Proteins Binding the Proform of Eosinophil Major Basic Protein in Human Pregnancy Serum and Plasma,”J. Biol. Chem., 1995, 270(23):13645-13651.
Oxvig et al., “Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein,”Biochim. Biophys. Acta, 1994, 1201:415-423.
Oxvig et al., “Circulating Human Pregnancy-associated Plasma Protein-A is Disulfide-bridged to the Proform of Eosinophil Major Basic Protein,”J. Biol. Chem., 1993, 268(17):12243-12246.
Popken-Harris et al., “Expression, Purification, and Characterization of the Recombinant Proform of Eosinophil Granule Major Basic Protein,”J. Immunol., 1995, 155:1472-1480.
Popken-Harris et al., “Regulation and Processing of a Precursor Form of Eosinophil Granule Major Basic Protein (ProMBP) in Differentiating Eosinophils,”Blood, 1998, 92(2):623-631.
Qin et al., “Double-monoclonal immunoflurometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome,”Clin. Chem., 1997, 43:2323-2332.
Resnick-Silverman et al., “Retinoblastoma Protein and Simian Virus 40-Dependent Immortalization of Human Fibroblasts,”J. Virol., 1991 65(6):2845-2852.
“Screening for Ovarian Cancer”[online]. National Cancer Institute, 2003, [retrieved on May 8, 2003]. Retrieved from the Internet:<URL: www.cancer.gov/cancerinfo/pdq/screening/ovarian/healthprofessionals> pp. 1-7.
Wagner et al., Analysis of Pregnancy-Associated Major Basic Protein Levels Throughout Gestation,Placenta, 1993, 14:671-681.
Wasmoen et al., “Biochemical and Amino Acid Sequence Analysis of Human Eosinophil Granule Major Basic Protein,”J. Biol. Chem., 1988, 263(25):12559-12563.
Weiss, “Hot Prospect for New Gene Amplifier,”Science, 254:1292-1293.
Welsh et al., “Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer,”Proc. Natl. Acad. Sci.USA, 2
Conover Cheryl A.
Kalli Kimberly R.
Fish & Richardson P.C.
Mayo Foundation for Medical Education and Research
Yaen Christopher H
LandOfFree
Methods of detecting ovarian neoplasia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of detecting ovarian neoplasia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of detecting ovarian neoplasia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4045443